← All Acura Pharmaceuticals, INC filings

Acura Pharmaceuticals, INC Form 4 insider transactions

Insider transactions: buys and sells by directors, officers and ten percent owners, filed within two business days of the trade.

OTC.Pink
ACUR
Acura Pharmaceuticals, INC
Form 4: ACURA Director Reports Equity Compensation Transactions
ACURA Pharmaceuticals Director Immanuel Thangaraj reported the exchange of restricted stock units for common stock and a new RSU grant, aligning executive interests.
OTC.Pink
ACUR
Acura Pharmaceuticals, INC
Form 4: Acura Pharma Director Converts RSUs, Gets New Grant
Acura Pharmaceuticals Director William G. Skelly converted 50,000 restricted stock units into common stock and received a new grant of 50,000 restricted stock units.
OTC.Pink
ACUR
Acura Pharmaceuticals, INC
Form 4: ACUR Director Ross Exchanges RSUs, Receives New Grant
Acura Pharmaceuticals Director George K. Ross reported an exchange of restricted stock units for common stock and received a new RSU grant.
OTC.Pink
ACUR
Acura Pharmaceuticals, INC
Form 4: Acura Pharmaceuticals Director Exercises Stock Options and Acquires Shares
Director Immanuel Thangaraj exercises restricted stock units for Acura Pharmaceuticals common stock and receives additional units.
OTC.Pink
ACUR
Acura Pharmaceuticals, INC
Form 4: Acura Pharmaceuticals Director William Skelly Acquires 50,000 Shares Through Restricted Stock Unit Exchange
Director William Skelly of Acura Pharmaceuticals acquired 50,000 shares of common stock through the exchange of restricted stock units on January 2, 2025.
OTC.Pink
ACUR
Acura Pharmaceuticals, INC
Form 4: Acura Pharmaceuticals Director Exercises Stock Options and Receives New Grant
Director George K. Ross exercised 50,000 restricted stock units for common stock and received a new grant of 50,000 restricted stock units.